ICNPU 2027

Loading

ICNPU 2027 · INVITED SPEAKER

Prof. Dr. Judith M. ROLLINGER

25–28 May 2027 · Plovdiv, Bulgaria

Lecture

From complexity to discovery: Rethinking natural product research through data and experimentation?

Biography

Univ.-Prof. Mag. pharm. Dr. Judith M. Rollinger

Professor at the Department of Pharmaceutical Sciences, Division of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Austria

Email: judith.rollinger@univie.ac.at

Website: Phytochemistry & Biodiscovery

ORCID: https://orcid.org/0000-0001-6581-0774

Judith M. Rollinger is Full Professor of Pharmacognosy/Pharmaceutical Biology and Head of “Phytochemistry & Biodiscovery” at the University of Vienna, Austria, where she pioneers data-driven strategies for nature-based drug discovery. Trained as a pharmaceutical scientist, her societal and scientific vision bridges natural product research with computational science to unlock the therapeutic potential of nature for pressing global health challenges.

Beyond her scientific achievements, Judith M Rollinger plays an active role in academic governance and strategic development. She has served as Senator of the University of Vienna since 2019, contributing to institutional decision-making at one of Europe’s leading research universities. At the international level, she has held a defining leadership role in the natural product community as President of the GA (Society for Medicinal Plant and Natural Product Research) from 2020 to 2023, with additional terms as Vice President. In these roles, she strengthened global collaboration, advanced nature-based drug discovery, and championed early career researchers.

Her research program integrates cheminformatics, biochemometry, and experimental phytochemistry as well as traditional medicine to discover novel natural lead structures targeting antimicrobial resistance, infectious diseases, metabolic syndrome, and inflammation. Beside several national and international collaborative projects, she currently coordinates the €2.5 million FWF-funded DocFunds program Anti-Infectives Drug Discovery – AIDD focusing on next-generation anti-infectives.